To further explore whether T lymphocytes mediate the anti‐tumor effect of LSS, we continued to examine the changes of tumor T lymphocytes, including CD8+ and CD4+ T lymphocytes, by flow cytometry (Figure 5A). The gene discussed is CD8A; the disease is neoplasm.